Last
Update:
August 14, 2010
Documents identified with this icon are in Portable Document Format (PDF)
and require the
Adobe
Acrobat Reader
Perinatal Journal Data are integrated with Perinatal Conference Data in
the Perinatal Data Page.
Pediatric Journal Data
are integrated with Pediatric Conference Data in
the Pediatric Data Page
XVIII
International AIDS Conference
|
|
Substitution of zidovudine for stavudine - outcome in India
K. Raja, R. Lakshmanabharathi, B.A. Mohamed Batcha,
et al
PDF Poster
Abstract
POSTER
A strategy to reduce new HIV infection, prevention and treatment: prolong
release
anti-HIV polymeric vaginal film - it's in vivo and in vitro drug release study
B.B. Bhowmik, A. Chatterjee, R. Thakuriam et al
PDF Poster
Abstract
POSTER
Neutropenia during 216 weeks of AZT-based anti-retroviral therapy among HIV
infected
patients in Africa in the DART trial
F. Ssali, J. Kayiwa, S. Walker, et al
PDF Poster
Abstract
|
-
POSTER
Prevalence of zidovudine-induced anemia using
laboratory monitoring in HIV/AIDS in Jos, Nigeria
C. Ramyil, I. Hauwa, L. Chindak, et al
PDF Poster
Abstract
-
POSTER
High-dose Zidovudine + Valganciclovir in the
Treatment of Kaposi’s Sarcoma-associated Herpesvirus-
associated Multicentric Castleman’s Disease: A Targeted Therapy Using Antiviral
Drugs that Are |
Activated to Toxic Moieties by Kaposi’s Sarcoma-associated Herpesvirus Lytic
Genes
T Uldrick, D O'Mahoney, K
Aleman, et al
PDF Poster
Abstract
XVII
International AIDS Conference
|
-
Short-course
Zidovudine and Lamivudine or single-dose Nevirapine-containing PMTCT
Compromises
12-Month
Response to HAART in African Women, Abidjan, Côte d’Ivoire (2003-2006)
P Coffie, D Ekouevi, ML
Chaix, et al
Abstract
-
Hematologic
Changes Associated with Zidovudine after Single-drug Substitution from
Stavudine
in a
Home-based AIDS Care Program in Rural Uganda
F Forna, D Moore, J Mermin,
et al
Abstract
-
Prevalence
of Anemia among Women in a Trial of HAART including Zidovudine for PMTCT in
Kisumu,
Kenya
T Thomas, R Masaba, R
Ndivo, et al
Abstract-
CONFERENCE PDF POSTER
A Mutation in the Connection
Subdomain of the HIV-1 Reverse Transcriptase (N348I) Is Selected
Commonly in vivo and Confers Decreased Susceptibility to Zidovudine and
Nevirapine
SH Yap, B Wynhoven,
M Kuiper, et al
PDF Poster
Abstract
-
Safety and
Early Virologic Response of Zidovudine + Lamivudine + Abacavir for Patients
Co-infected
with HIV and TB in Uganda
P Srikantiah, M Walusimbi,
H Kayanja, et al
Abstract
-
Mechanism of
Synergy between Efavirenz and Zidovudine: Role of HIV-1 Reverse Transcriptase
RNase H
Activity
J Radzio, N
Sluis-Cremer
Abstract
-
Cell-dependent Compartmentalization of Zidovudine- and Lamivudine-triphosphate
Concentrations in
HIV-seronegative Adults
PL. Anderson, J H Zheng, J
Gerber, et al
Abstract
8th Int Congress on Drug Therapy in HIV
Infection
|
XVI
International AIDS Conference
|
-
Bioavailability of two formulations of zidovudine 100mg: a randomized,
open-label, two-period
crossover comparison in 30 healthy adult subjects
Ferrari I., Mahler E., Custidiano A., et al
Abstract
-
Treatment initiation with zidovudine-containing HAART leads to a lower rise in
the absolute CD4
cell count but does not increase the risk of clinical
progression
Lahn A., Kaufmann G., Battegay M., et al
Abstract
-
Lack
of clinically relevant drug-drug interaction between the ritonavir-boosted HIV
integrase inhibitor
GS-9137/r and zidovudine (ZDV)
Ramanathan S., Lagan K., Plummer A., et al
Abstract
-
Development of zidovudine dosing regimen for co-formulation with amdoxovir
Hurwitz S.J., Asif G., Kivel N.M., Schinazi R.F.
Abstract
-
Clinically-significant anemia in HIV-infected pregnant women in India is not a
major barrier to use
of zidovudine for prevention of maternal to child transmission
G. Sinha, J. Choi, U. Nayak
Abstract -
Evolution of hematologic parameters in Thai HIV-infected pregnant women
initiating zidovudine
prophylaxis at 28 weeks’ or 35 weeks gestation
N. Briand, S. Le Coeur, G. Jourdain, et al
Abstract
A
Novel and Rare Amino Acid Substitution E40F in HIV-1 Reverse
Transcriptase Increases
Zidovudine Resistance and Decreases Replication Capacity
M Huigen, P Van Ham, L De Graaf, et al
Abstract
Intensification of a Failing Regimen with Zidovudine May Cause Sustained
Virologic
Suppression in the Presence of the K65R Mutation
S Staszewski, B Dauer, L Locher, et al
Abstract
A Randomized Trial of Early vs Delayed Fixed-dose Combination
Zidovudine/Lamivudine/Abacavir
in Patients Co-infected with HIV and Tuberculosis: Early Findings of
the Tuberculosis and HIV
Immune Reconstitution Syndrome Trial
H Shao, J Crump,
H Ramadhani,, et al
Abstract
R. GULICK, H. RIBAUDO, C. SHIKUMA ,
et al
Abstract
Evolution of Bone Mineral Density in AIDS Patients on Treatment with
Zidovudine, Lamivudine and Abacavir
P. RIVAS, M. GÓRGOLAS, M. DÍAZ-CURIEL, et al
Abstract
Abstract
Characterization of anemia in HIV-infected (HIV+) subjects treated with
antiretroviral therapy
(ART)
with and without zidovudine (+/-ZDV) in 54 clinical trials
Edwards M., Burkle W., Cutrell A., et al
Abstract
An
Observational Cohort Comparison of Zidovudine-Lamivudine-Efavirenz vs.
Tenofovir-
Lamivudine-Efavirenz in Anti-retroviral Naïve Patients in a Large Urban
Clinic.
Keiser P., Nassar N., Armas L.,et al
Abstract
|
Zidovudine
Conference Citations
|
|
XVIII
International AIDS Conference
